Non-Hodgkin's lymphoma in the Netherlands: Results from a population based registry

Leukemia and Lymphoma

Volumn 44, Issue 3, 2003, Pages 451-458

  Krol, A D G ^a   Le Cessie, S ^a   Snijder, S ^b   Kluin Nelemans, J C ^c   Kluin, Ph M ^c   Noordijk, E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum West   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Diffuse large B cell lymphoma; Follicular lymphoma; Non Hodgkin's lymphoma; Relative survival; Survival

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CENTER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STATISTICS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHODGKIN LYMPHOMA; PATIENT INFORMATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE TABLES; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; REGISTRIES; REMISSION INDUCTION; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037344995     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000038010     Document Type: Article

References (39)

1. Haak, H.L., Kluin, P.M., Meyer, C.J., Otter, R., Stijnen, T., Bieger, R., et al. (1986) "Population-based registration of non-Hodgkin's lymphoma in the region covered by the Comprehensive Cancer Centre West. The registry of diagnosis and therapy", Neth. J. Med. 29, 105-110.
2. Otter, R., "Non-Hodgkin's Lymphoma in a Population-Based Registry" Thesis, (Pasmans, Gravenhage).
3. Otter, R., Gerrits, W.B., Sandt, M.M., Hermans, J. and Willemze, R. (1989) "Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry", Eur. J. Cancer Clin. Oncol. 25, 1203-1210.
4. Otter, R., Bieger, R., Kluin, P.M., Hermans, J. and Willemze, R. (1989) "Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry", Br. J. Cancer 60, 745-750.
5. van Krieken, J.H., Otter, R., Hermans, J., van Groningen, K., Spaander, P.J., van de Sandt, M.M., et al. (1989) "Malignant lymphoma of the gastrointestinal tract and mesentery. A clinicopathologic study of the significance of histologic classification. NHL Study Group of the Comprehensive Cancer Centre West", Am. J. Pathol. 135, 281-289.
6. Raghoebier, S., Kramer, M.H., van Krieken, J.H., de Jong, D., Limpens, J., Kluin-Nelemans, J.C., et al. (1991) "Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma", Blood 78, 2680-2685.
7. Hermans, J., Krol, A.D., van Groningen, K., Kluin, PM., Kluin-Nelemans, J.C., Kramer, M.H., et al. (1995) "International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades", Blood 86, 1460-1463.
8. Velders, G.A., Kluin-Nelemans, J.C., De Boer, C.J., Hermans, J., Noordijk, E.M., Schuuring, E., et al. (1996) "Mantle-cell lymphoma: a population-based clinical study", J. Clin. Oncol. 14, 1269-1274.
9. Kramer, M.H., Hermans, J., Parker, J., Krol, A.D., Kluin-Nelemans, J.C., Haak, H.L., et al. (1996) "Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study", J. Clin. Oncol. 14, 2131-2138.
10. Krol, A.D., Hermans, J., Kramer, M.H., Kluin, P.M., Kluin-Nelemans, H.C., Blok, P., et al. (1997) "Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival", Cancer 79, 390-397.
11. Krol, A.D., Hermans, J., Dawson, L., Snijder, S., Wijermans, P.W., Kluin-Nelemans, H.C., et al. (1998) "Treatment, patterns of failure, and survival of patients with Stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the Comprehensive Cancer Centre West", Cancer 83, 1612-1619.
12. Kramer, M.H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E., van Krieken, J.H., et al. (1998) "Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma", Blood 92, 3152-3162.
13. Maartense, E., Hermans, J., Kluin-Nelemans, J.C., Kluin, P.M., Van Deijk, W.A., Snijder, S., et al. (1998) "Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands", Ann. Oncol. 9, 1219-1227.
14. Drillenburg, P., Wielenga, V.J., Kramer, M.H., van Krieken, J.H., Kluin-Nelemans, H.C., Hermans, J., et al. (1999) "CD44 expression predicts disease outcome in localized large B cell lymphoma", Leukemia 13, 1448-1455.
15. Maartense, E., Kluin-Nelemans, H.C., le Cessie, S., Kluin, P.M., Snijder, S. and Noordijk, E.M. (2000) "Different age limits for elderly patients with indolent and aggressive non-Hodgkin's lymphoma and the role of relative survival with increasing age", Cancer 89, 2667-2676.
16. Krol, A.D., le Cessie, S., Snijder, S., Kluin-Nelemans, J.C., Kluin, P.M. and Noordijk, E.M. (2001) "Waldeyer's ring lymphomas: a clinical study from the Comprehensive Cancer Centre West population based NHL registry", Leuk. Lymphoma 42, 1005-1013.
17. Lennert, K. (1978) Malignant lymphomas other than Hodgkin's disease (Springer Verlag, New York, NY).
18. Lennert, K. (1992) Histopathology of Non-Hodgkin's Lymphomas (Springer Verlag, New York, NY), Ref Type: Generic.
19. The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) "National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage", Cancer 49, 2112-2135.
20. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361-1392.
21. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. and Tubiana, M. (1971) "Report of the Committee on Hodgkin's Disease Staging Classification", Cancer Res. 31, 1860-1861.
22. The International Non-Hodgkin's Lymphoma Prognostic Factors Project(1993) "A predictive model for aggressive non-Hodgkin's lymphoma", N. Engl. J. Med. 329,987-994.
23. Hakulinen, T. (1999) "Methodological problems in comparing incidence and prevalence of leukaemias and lymphomas: ascertainment and age adjustment", Leukemia 13(Suppl. 1), S37-S41.
24. Visser, O., Coebergh, J.W., Schouten, L.J. and van Dijck, J.A.A.M. (1997) Incidence of cancer in the Netherlands (Vereniging van Integrale Kankercentra, Utrecht), p 2001.
25. Cartwright, R., Brincker, H., Carli, P.M., Clayden, D., Coebergh, J.W., Jack, A., et al. (1999) "The rise in incidence of lymphomas in Europe 1985-1992", Eur. J. Cancer 35, 627-633.
26. Groves, F.D., Linet, M.S., Travis, L.B. and Devesa, S.S. (2000) "Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995", J. Natl Cancer Inst. 92, 1240-1251.
27. Newton, R., Ferlay, J., Beral, V. and Devesa, S.S. (1997) "The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites", Int. J. Cancer 72, 923-930.
28. Devesa, S.S. and Fears, T. (1992) "Non-Hodgkin's lymphoma time trends: United States and international data", Cancer Res. 52, 5432s-5440s.
29. Fisher, R.I. (1997) "Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma", Cancer Chemother. Pharmacol. 40(Suppl.), S42-S46.
30. Pittaluga, S., Bijnens, L., Teodorovic, I., Hagenbeek, A., Meerwaldt, J.H., Somers, R., et al. (1996) "Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation", Blood 87, 4358-4367.
31. Decaudin, D., Lepage, E., Brousse, N., Brice, P., Harousseau, J.L., Belhadj, K., et al. (1999) "Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients-a study of the groupe d'Etude des lymphomas de l'Adulte", J. Clin. Oncol. 17, 2499-2505.
32. The Non-Hodgkin's Lymphoma Classification Project (1997) "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma", Blood 89, 3909-3918.
33. Armitage, J.O. and Weisenburger, D.D. (1998) "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project", J. Clin. Oncol. 16, 2780-2795.
34. Varterasian, M.L., Graff, J.J., Severson, R.K., Weiss, L., al Katib, A.M. and Kalemkerian, G.P. (2000) "Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database", Cancer Investig. 18, 303-308.
35. Carli, P.M., Coebergh, J.W. and Verdecchia, A. (1998) "Variation in survival of adult patients with haematological malignancies in Europe since 1978", Eur. J. Cancer 34, 2253-2263.
36. Wood, L.A., Coupland, R.W., North, S.A. and Palmer, M.C. (1999) "Outcome of advanced stage low grade follicular lymphomas in a population-based retrospective cohort", Cancer 85, 1361-1368.
37. Federico, M., Vitolo, U., Zinzani, P.L., Chisesi, T., Clo, V., Bellesi, G., et al. (2000) "Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi", Blood 95, 783-789.
38. Miller, T.P., LeBlanc, M., Grogan, T.M. and Fisher, R.I. (1997) "Follicular lymphomas: do histologic subtypes predict outcome?", Hematol. Oncol. Clin. N. Am. 11, 893-900.
39. Tirelli, U., Errante, D., Van Glabbeke, M., Teodorovic, I., Kluin-Nelemans, J.C., Thomas, J., et al. (1998) "CHOP is the standard regimen in patients ≥ 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group", J. Clin. Oncol. 16, 27-34.